Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 22, 2013

Primary Completion Date

January 6, 2017

Study Completion Date

January 6, 2017

Conditions
Prostate CancerPancreatic CancerBladder Cancer
Interventions
RADIATION

[124I] PSCA-Minibody PET/CT imaging of the whole body

Whole body Imaging

Trial Locations (1)

90024

University of California, Los Angeles, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ImaginAb, Inc.

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER